Rationale and protocol for a safety, tolerability and feasibility randomized, parallel group, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms. uri icon

authors

  • Stubbs, Brianna J
  • Upadhyay, Vaibhav
  • Turnbaugh, Peter J
  • Johnson, James B
  • John Newman, MD, PhD
  • Alvarez-Azanedo, Gabriela
  • Peralta, Sawyer
  • Roa-Diaz, Stephanie
  • Gray, Wyatt
  • Alexander, Laura
  • Silverman-Martin, Wendie
  • Garcia, Thelma
  • Blonquist, Traci M

publication date

  • October 26, 2023